Related Experiment Videos
An update on prostate cancer research.
1University of California, San Francisco, Comprehensive Cancer Center, 94115, USA. smalle@medicine.ucsf.edu
Current Opinion in Oncology
|June 7, 2000
Summary
Understanding prostate cancer involves environmental and genetic factors. Advances in molecular mechanisms, screening, and risk assessment improve early detection and treatment, though novel therapies are needed for advanced disease.
Area of Science:
- Oncology
- Genetics
- Environmental Health
Background:
- Prostate cancer pathogenesis involves complex environmental and genetic interactions.
- Molecular mechanisms are increasingly explaining geographic and ethnic variations in incidence.
- Understanding of molecular disease progression is rapidly advancing.
Purpose of the Study:
- To review recent advances in prostate cancer pathogenesis, screening, risk assessment, and treatment.
- To highlight the role of molecular markers in disease progression and patient stratification.
- To discuss current and needed therapeutic strategies for both localized and advanced prostate cancer.
Main Methods:
- Review of recent scientific literature on prostate cancer.
- Analysis of molecular mechanisms underlying disease variations.
- Evaluation of clinical advancements in screening, risk assessment, and treatment.
Main Results:
- Prostate cancer mortality rates are declining due to early detection and treatment.
- Improved risk assessment tools are available, with a need for validated molecular markers.
- Treatment options for localized and androgen-independent prostate cancer have expanded.
Conclusions:
- Continued research into molecular mechanisms is crucial for understanding prostate cancer.
- Enhanced screening and risk assessment improve patient outcomes.
- Novel therapeutic strategies are essential to improve survival for patients with advanced prostate cancer.